BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19959238)

  • 1. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.
    Lewis RD; Jackson CL; Morgan BP; Hughes TR
    Mol Immunol; 2010 Feb; 47(5):1098-105. PubMed ID: 19959238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.
    Wu G; Hu W; Shahsafaei A; Song W; Dobarro M; Sukhova GK; Bronson RR; Shi GP; Rother RP; Halperin JA; Qin X
    Circ Res; 2009 Feb; 104(4):550-8. PubMed ID: 19131645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
    Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
    J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
    An G; Miwa T; Song WL; Lawson JA; Rader DJ; Zhang Y; Song WC
    Mol Immunol; 2009 May; 46(8-9):1702-9. PubMed ID: 19297024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.
    Yun S; Leung VW; Botto M; Boyle JJ; Haskard DO
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1714-6. PubMed ID: 18617646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD59a is the primary regulator of membrane attack complex assembly in the mouse.
    Baalasubramanian S; Harris CL; Donev RM; Mizuno M; Omidvar N; Song WC; Morgan BP
    J Immunol; 2004 Sep; 173(6):3684-92. PubMed ID: 15356114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.
    Miwa T; Zhou L; Maldonado MA; Madaio MP; Eisenberg RA; Song WC
    J Immunol; 2012 Dec; 189(11):5434-41. PubMed ID: 23109726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.
    Li B; Xu YJ; Chu XM; Gao MH; Wang XH; Nie SM; Yang F; Lv CY
    Immunol Lett; 2013; 156(1-2):68-81. PubMed ID: 24084445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.
    Stahel PF; Flierl MA; Morgan BP; Persigehl I; Stoll C; Conrad C; Touban BM; Smith WR; Beauchamp K; Schmidt OI; Ertel W; Leinhase I
    J Neuroinflammation; 2009 Jan; 6():2. PubMed ID: 19133139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration.
    Bora NS; Kaliappan S; Jha P; Xu Q; Sivasankar B; Harris CL; Morgan BP; Bora PS
    J Immunol; 2007 Feb; 178(3):1783-90. PubMed ID: 17237428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.
    Morgan BP; Chamberlain-Banoub J; Neal JW; Song W; Mizuno M; Harris CL
    Clin Exp Immunol; 2006 Nov; 146(2):294-302. PubMed ID: 17034582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of the sixth complement component and, spatial and temporal expression profile of MAC structural and regulatory genes in chicken.
    Mikrou A; Zarkadis IK
    Dev Comp Immunol; 2010 May; 34(5):485-90. PubMed ID: 20067805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis.
    Williams AS; Mizuno M; Richards PJ; Holt DS; Morgan BP
    Arthritis Rheum; 2004 Sep; 50(9):3035-44. PubMed ID: 15457473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a central role for complement in osteoarthritis.
    Wang Q; Rozelle AL; Lepus CM; Scanzello CR; Song JJ; Larsen DM; Crish JF; Bebek G; Ritter SY; Lindstrom TM; Hwang I; Wong HH; Punzi L; Encarnacion A; Shamloo M; Goodman SB; Wyss-Coray T; Goldring SR; Banda NK; Thurman JM; Gobezie R; Crow MK; Holers VM; Lee DM; Robinson WH
    Nat Med; 2011 Nov; 17(12):1674-9. PubMed ID: 22057346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis.
    Mead RJ; Neal JW; Griffiths MR; Linington C; Botto M; Lassmann H; Morgan BP
    Lab Invest; 2004 Jan; 84(1):21-8. PubMed ID: 14631387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement regulatory protein CD59a plays a protective role in immune liver injury of trichloroethylene-sensitized BALB/c mice.
    Wang X; Yu Y; Xie HB; Shen T; Zhu QX
    Ecotoxicol Environ Saf; 2019 May; 172():105-113. PubMed ID: 30685621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component 6 deficiency increases susceptibility to dextran sulfate sodium-induced murine colitis.
    Ding P; Li L; Huang T; Yang C; Xu E; Wang N; Zhang L; Gu H; Yao X; Zhou X; Hu W
    Immunobiology; 2016 Nov; 221(11):1293-303. PubMed ID: 27316715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
    Elvington A; Atkinson C; Zhu H; Yu J; Takahashi K; Stahl GL; Kindy MS; Tomlinson S
    J Immunol; 2012 Nov; 189(9):4640-7. PubMed ID: 23028050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
    Zhang H; Verkman AS
    J Autoimmun; 2014 Sep; 53():67-77. PubMed ID: 24698947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.